1440PRandomised phase II trial of oral vinorelbine (OV) and cisplatin (P) followed by maintenance with OV versus gemcitabine (GEM) and P followed by maintenance with GEM as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC) patients (pts) with squamous (sq) histological type. (23rd October 2018) - Grossi, F; Jaskiewicz, P; Pichon, E; Czyzewicz, G; Kowalski, D M; Ciuffreda, L; Garcia Gomez, R; Caruso, S; Bosch Barrera, J; Ta Thanh Minh, C; Gautier, S; Hervieu, H; et al.